HCM
ELV icon

HMS Capital Management’s Elevance Health ELV Stock Holding History

HMS Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,906
Closed -$899K – 113
2023
Q4 		$899K Sell
1,906
-201
-10% -$92.9K 0.55% 42
2023
Q3 		$917K Sell
2,107
-85
-4% -$38.6K 0.61% 46
2023
Q2 		$974K Buy
2,192
+95
+5% +$43.8K 0.59% 45
2023
Q1 		$964K Buy
+2,097
New +$998K 0.61% 45

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HMS Capital Management's ELV Position: Q1 2024 in Review

HMS Capital Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,906 shares — an estimated $899K sold.

HMS Capital Management first reported a position in ELV in Q1 2023 and held it in 4 quarters. The position peaked at $974K in Q2 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • HMS Capital Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • HMS Capital Management sold 1,906 Elevance Health shares in Q1 2024, an estimated $899K.
  • HMS Capital Management first reported a position in Elevance Health in Q1 2023 and held it in 4 quarters.
  • HMS Capital Management's Elevance Health position peaked at $974K in Q2 2023.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on HMS Capital Management's 13F filing for Q1 2024, filed 24 Apr 2024.